You just read:

Asia-Pacific Type 2 Diabetes Mellitus Therapeutics in Markets to 2021 - Markets is Expected to Increase in Value at a CAGR of 7.7%, from $6.07 Billion to Over $10.2 Billion - Research and Markets

News provided by

Research and Markets

Apr 26, 2016, 09:10 ET